P
Progyny
Leading fertility benefits company that combines service, science, technology and data to provide fertility solutions for self-insured employers
About Progyny
Progyny, Inc. (website: progyny.com) is a leading fertility benefits management company that aims to provide comprehensive and inclusive fertility and family-building benefits. The company operates primarily in the healthcare and insurance markets, focusing on fertility treatments and family-building services. Progyny serves a diverse range of clients, including large employers who want to offer fertility benefits to their employees, as well as employees advocating for these benefits within their organizations.
Progyny's business model is centered around partnering with employers to integrate fertility benefits into their existing employee benefits packages. The company offers a wide array of services, including intrauterine insemination (IUI), in vitro fertilization (IVF), fertility preservation, adoption assistance, and surrogacy support. By providing these services, Progyny aims to improve clinical outcomes and reduce the overall costs associated with fertility treatments.
The company makes money through contracts with employers who pay for Progyny's services as part of their employee benefits offerings. These contracts typically involve a fixed fee or a per-employee-per-month (PEPM) pricing model. Progyny's value proposition lies in its ability to deliver superior clinical outcomes, which consistently exceed national averages, and its seamless integration into existing benefits ecosystems.
Progyny's market is driven by the increasing demand for fertility and family-building benefits, as more employers recognize the importance of supporting their employees' reproductive health. The company has been recognized for its rapid growth, ranking on financial lists for the fastest-growing companies for three consecutive years.
In summary, Progyny is a specialized fertility benefits management company that partners with employers to provide comprehensive and inclusive fertility and family-building services, generating revenue through employer contracts.
Source: Dealroom company dataAt a glance
- Status
- Listed
- Founded
- 2008
- Headquarters
- New York City, United States
- Listing
- IPO 2019
- Sector
- Health Tech & Medtech
- Power Law
- Unicorn$1–10B valuation tierThoroughbred$100M+ revenue
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A5 investors entered at this stage
SR One
Kleiner Perkins
TPG Biotech
Union Grove Venture Partners
M Ventures
Series B and later2 investors entered at this stage
Pete Anevski
David Schlanger
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Patents
12 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Progyny on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Progyny on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.
